On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< SPY SPDR S&P 500 ETF Trust - 02/14/22
- Jana Partners added Zendesk in Q4, sold out of Vonage, CyrusOne
- 03/29/22
- St. Louis Fed chief Bullard's says FOMC 'must now' increase 'policy rates'
- 03/01/22
- S&P Dow Jones says no Russian stocks to be added to indices
- 02/11/22
- Markets move lower after PBS report on U.S. seeing Ukraine invasion
- 02/11/22
- Gundlach thinks 10-year note yield can 'make a move toward 2.50'
- $526.34 /
-79.66 (-13.15%) - 04/20/22
- Shopify falls -9.6%
- 04/11/22
- Shopify announces planned 10-for-1 split of Class A and Class B shares
- 04/11/22
- Shopify announces proposed updates to governance structure
- 03/28/22
- Shopify purchases carbon removal credits from CarbonBuilt
RCI Rogers Communications - 04/19/22
- Rogers announces production test of 8 gbps symmetrical fibre broadband
- 04/04/22
- Rogers Communications to deploy two more cellular towers along Highway 16
- 04/04/22
- Rogers Communications, OVIN launch 5G transportation challenge
- 03/28/22
- Rogers Communications launches 5G standalone network in Canada
- 04/20/22
- Rite Aid higher after resumption, up 33% after Post report of rejected bid
- 04/20/22
- Rite Aid trading resumes
- 04/20/22
- Rite Aid up 16%, halted for volatility after Post reports takeover bid rejected
- 04/20/22
- Rite Aid trading halted, volatility trading pause
- 04/20/22
- Procter & Gamble seeing 'significant' impact from China lockdowns
- 04/20/22
- P&G expects to repurchase $10B of stock this year, pay over $8B in dividends
- 04/20/22
- Procter & Gamble sees EPS impact of Russia-Ukraine pullback of 4c in Q4
- 04/20/22
- Procter & Gamble backs FY22 core EPS growth view of 3%-6%
- $225.99 /
-122.52 (-35.16%) - 04/19/22
- Netflix says will figure out advertising in next year or two
- 04/19/22
- Netflix says Q2 typically a softer quarter seasonally
- 04/19/22
- Netflix to test ways to charge for account sharing this year
- 04/19/22
- Roku drops 6% to $109.96 after Netflix losses subscribers in Q1
- $385.44 /
-19.35 (-4.78%) - 04/20/22
- Lululemon announces five year growth plan to double revenue to $12.5B by 2026
- 04/12/22
- Lululemon expands Like New resale program to all U.S. stores
- 03/29/22
- Lululemon jumps 7% to $369.33 after FY22 guidance beats estimates
- 03/29/22
- Lululemon authorizes buyback for $1.0B
- 03/31/22
- I-Mab announces voluntary lock-ups by key shareholders
- 03/15/22
- I-Mab provides update on the HFCAA and its implementation
- 03/03/22
- I-Mab's TJ-CD4B in gastric cancer granted FDA Orphan Drug Designation
- 03/02/22
- I-Mab granted orphan status for gastric cancer treatment
- $138.30 /
+9.005 (+6.96%) - 04/19/22
- IBM now sees FY22 revenue growth at high end of mid single digit range
- 04/19/22
- IBM up 3% to $133.50 after Q1 results beat estimates
- 04/19/22
- IBM reports Q1 net cash from operating activities of $3.2B; free cash flow $1.2B
- 04/19/22
- IBM CEO says 'we are off to a solid start for the year'
- 04/19/22
- Halliburton records Q1 pre-tax charge of $22M from write down of Ukraine assets
- 04/19/22
- Halliburton sees significant tightness across the entire oil and gas value chain
- 03/18/22
- Halliburton suspends future business in Russia, winds down remaining operations
- 03/08/22
- Halliburton awarded contract by Petrobel
- $2,565.37 /
-46.84 (-1.79%) - 04/14/22
- YouTube, MLB renew pact over MLB Game of the Week Live
- 04/13/22
- Regulator allows WhatsApp to extend payment services to 100M users in India
- 04/13/22
- Google to invest $9.5B in the U.S. in 2022
- 04/12/22
- MongoDB announces pay-as-you-go offering on Google Cloud
- 12/17/21
- Farmers & Merchants raises Q4 cash dividend payment by 11.8% to 19c per share
- $200.48 /
-16.78 (-7.72%) - 04/18/22
- Instagram expanding product tagging in Feed to everyone
- 04/14/22
- WhatsApp debuts Communities, new tools for administrators to monitor abuse
- 04/13/22
- eBay names Eddie Garcia as Chief Product Officer
DWAC Digital World Acquisition - 04/20/22
- Trump-linked SPAC Digital World falls after Kerrisdale short report
- 04/20/22
- Digital World Acquisition SPAC down 8% after being named a short by Kerrisdale
- 03/31/22
- Trump SPAC falls as Truth Social downloads sink 95% from launch
- 03/14/22
- Trump SPAC sinks as Truth Social drops out of App Store's top 125
- $319.26 /
+34.93 (+12.29%) - 11/19/21
- Avis Budget chairman Hees sells 43,389 common shares
- 11/17/21
- Avis Budget chairman sells 100K shares of common stock
- 11/02/21
- Avis Budget halts for volatility after 56% move higher
- 04/20/22
- Cano Health rises 10.5%
- 04/20/22
- Cano Health rises 10.3%
- 04/06/22
- Cano Health falls -9.4%
- 03/15/22
- Cano Health rises 9.4%
- $120.42 /
+2.865 (+2.44%) - 04/19/22
- American Campus to be acquired by Blackstone for $65.47 per share in cash
- 03/15/22
- Sanofi, Blackstone announces EUR 300M multiple myeloma collaboration
- 03/14/22
- Blackstone acquires 49% stake in One Manhattan West in deal valued at $2.85B
- 03/01/22
- Blackstone director Porat acquires 5,000 common shares
- 04/14/22
- Baker Hughes reports U.S. rig count up 4 to 693 rigs
- 04/14/22
- Baker Hughes reports U.S. rig count up 4 to 693 rigs
- 04/08/22
- Baker Hughes reports U.S. rig count up 16 to 689 rigs
- 04/08/22
- Baker Hughes reports U.S. rig count up 16 to 689 rigs
ARCT Arcturus Therapeutics - 04/20/22
- Arcturus: mRNA vaccine candidate ARCT-154 meets primary efficacy endpoint
- 02/23/22
- Avidity Biosciences names Steve Hughes, M.D. as Chief Medical Officer
- 02/14/22
- Arcturus Therapeutics says Hughes steps down as Chief Medical Officer
- 01/25/22
- Arcturus reports new data on ARCT-154 and ARCT-165 booster clinical trial
- 04/20/22
- Anthem: Medical enrollment totaled 46.8M members at March 31
- 03/10/22
- Anthem announces intent to change name to Elevance Health
- 02/03/22
- CMS releases 2023 Medicare Advantage, Part D advance notice
- 01/26/22
- Anthem sees FY22 medical membership 45.6M-46.2M
- 04/20/22
- AlloVir trading resumes
- 04/20/22
- AlloVir trading halted, volatility trading pause
- 04/20/22
- AlloVir receives FDA RMAT designation for posoleucel
- 03/22/22
- AlloVir initiates posoleucel registrational study
- 04/19/22
- Alkermes begins arbitration regarding two license agreements with Janssen
- 02/17/22
- Alkermes presents new data on nemvaleukin alfa monotherapy
- 02/08/22
- Alkermes reports 'positive' results from ENLIGHTEN-Early study
- 01/11/22
- Sarissa intends to nominate directors to Alkermes board
- 04/20/22
- Abbott says seeing more Covid tests, sales
- 04/20/22
- Abbott sees FY22 organic sales growth mid to high single digits
- 04/20/22
- Abbott says continues to strengthen strategic position
- 04/20/22
- Abbott reports Q1 Worldwide Diagnostics sales up 31.7% on a reported basis
- 02/11/22
- Gundlach says 'never been long or short crypto,' too volatile for him
- 02/11/22
- Gundlach wouldn't expect weakness in risk assets going into Fed's March meeting
- 02/11/22
- Gundlach sees 'stability' in near-term for U.S. equities
- $225.99 /
-122.52 (-35.16%) - 04/21/22 Benchmark
- Roku price target lowered to $240 from $305 at Benchmark
- 04/21/22 Citi
- Netflix price target lowered to $295 from $450 at Citi
- 04/21/22 Edward Jones
- Netflix downgraded to Hold from Buy at Edward Jones
- 04/21/22 DZ Bank
- Netflix downgraded to Hold from Buy at DZ Bank
- 04/21/22 Raymond James
- Procter & Gamble price target raised to $180 from $175 at Raymond James
- 04/21/22 Credit Suisse
- Procter & Gamble price target raised to $150 from $140 at Credit Suisse
- 04/08/22 Raymond James
- Procter & Gamble initiated with an Outperform at Raymond James
- 04/07/22 Raymond James
- Procter & Gamble initiated with an Outperform at Raymond James
- $138.30 /
+9.005 (+6.96%) - 04/20/22 BMO Capital
- IBM price target raised to $152 from $148 at BMO Capital
- 04/20/22 BofA
- IBM price target raised to $165 from $162 at BofA
- 04/20/22 Morgan Stanley
- IBM price target raised to $157 from $150 at Morgan Stanley
- 04/14/22 Morgan Stanley
- IBM upgraded to Overweight from Equal Weight at Morgan Stanley
- $385.44 /
-19.35 (-4.78%) - 04/19/22 Truist
- Lululemon upgraded to Buy from Hold at Truist
- 04/12/22 Stifel
- Lululemon resale expansion 'strategic and shareholder beneficial,' says Stifel
- 04/12/22 Cowen
- Lululemon upside to consensus estimates seen, says Cowen
- 04/07/22 Truist
- Lululemon price target raised to $390 from $386 at Truist
- 03/07/22 Citi
- Citi lowers year-end 2022 S&P 500 target on geopolitical risk
- 02/18/22 Stifel
- Stifel says S&P 500 correction in Q1 isn't over
- 02/17/22 JPMorgan
- JPMorgan now expects seven rate hikes in this year, up from five
- 01/24/22 JPMorgan
- JPMorgan macro strategist says market correction in final stages
SPY SPDR S&P 500 ETF Trust - 11/22/21 BTIG
- In picking Powell, Biden went with 'safest choice,' says BTIG
- 08/04/21 Citi
- Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
- $2,565.37 /
-46.84 (-1.79%) - 04/21/22 Credit Suisse
- Alphabet price target lowered to $3,450 from $3,500 at Credit Suisse
- 04/20/22 KeyBanc
- Alphabet, Trade Desk should see the least fundamental risk, says KeyBanc
- 04/19/22 Citi
- Alphabet assumed with a Buy from Neutral at Citi
- 04/19/22 Rosenblatt
- Alphabet initiated with a Buy at Rosenblatt
- $2,562.24 /
-35.41 (-1.36%) - 04/20/22 RBC Capital
- Halliburton price target raised to $49 from $45 at RBC Capital
- 04/20/22 Stephens
- Halliburton downgraded to Equal Weight at Stephens following outperformance
- 04/20/22 Stephens
- Halliburton downgraded to Equal Weight from Overweight at Stephens
- 04/20/22 Susquehanna
- Halliburton price target raised to $48 from $45 at Susquehanna
- $319.26 /
+34.93 (+12.29%) - 04/20/22 Barclays
- Barclays upgrades Avis to neutral on 'constructive' rental stance
- 04/20/22 Barclays
- Avis Budget upgraded to Equal Weight from Underweight at Barclays
- 04/06/22 BofA
- Avis Budget downgraded to Underperform from Neutral at BofA
- 04/06/22 BofA
- Avis Budget downgraded to Underperform from Neutral at BofA
- 04/20/22 Goldman Sachs
- Alkermes initiated with a Buy at Goldman Sachs
- 03/22/22 Citi
- Alkermes price target raised to $26 from $22 at Citi
- 02/17/22 Mizuho
- Alkermes price target raised to $35 from $33 at Mizuho
- 01/27/22 Cantor Fitzgerald
- Alkermes upgraded to Overweight from Neutral at Cantor Fitzgerald
- 03/30/22 H.C. Wainwright
- I-Mab price target lowered to $80 from $95 at H.C. Wainwright
- 03/29/22 Piper Sandler
- I-Mab price target lowered to $80 from $90 at Piper Sandler
- 09/03/21 Cantor Fitzgerald
- Cantor Fitzgerald positive on I-Mab following 'solid' first half
- 09/01/21 H.C. Wainwright
- I-Mab price target raised to $95 from $75 at H.C. Wainwright
DWAC Digital World Acquisition - $526.34 /
-79.66 (-13.15%) - 04/19/22 Piper Sandler
- Shopify price target lowered to $800 from $900 at Piper Sandler
- 04/13/22 Benchmark
- Shopify initiated with Hold on 'tough' environment at Benchmark
- 04/13/22 Benchmark
- Shopify initiated with a Hold at Benchmark
- 04/11/22 ATB Capital
- Shopify's 'shareholder friendly changes' positive for shares, says ATB Capital
- $200.48 /
-16.78 (-7.72%) - 04/21/22 Credit Suisse
- Meta Platforms price target lowered to $272 from $336 at Credit Suisse
- 04/19/22 Citi
- Meta Platforms assumed with Buy from Neutral at Citi
- 04/19/22 JMP Securities
- Meta Platforms price target lowered to $265 from $350 at JMP Securities
- $120.42 /
+2.865 (+2.44%) - 04/12/22 Citi
- Blackstone price target lowered to $117 from $132.50 at Citi
- 04/07/22 Deutsche Bank
- Blackstone price target raised to $186 from $180 at Deutsche Bank
- 04/07/22 Exane BNP Paribas
- Blackstone downgraded to Neutral from Outperform at Exane BNP Paribas
- 03/23/22 Truist
- Preferred Apartment price target raised to $25 from $17 at Truist
- 04/18/22 Deutsche Bank
- Rite Aid price target raised to $2 from $1 at Deutsche Bank
- 04/07/22 Deutsche Bank
- Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
- 04/07/22 Deutsche Bank
- Rite Aid downgraded to Sell from Hold at Deutsche Bank
- 10/20/21 Deutsche Bank
- Rite Aid price target raised to $15 from $13 at Deutsche Bank
- 03/22/22 Piper Sandler
- Piper 'incrementally positive' on AlloVir after posoleucel data
- 01/31/22 BMO Capital
- AlloVir initiated with an Outperform at BMO Capital
- 01/31/22 BofA
- AlloVir removed from US 1 List at BofA
- 10/19/21 Morgan Stanley
- AlloVir assumed with an Overweight at Morgan Stanley
- 04/20/22 UBS
- Cano Health initiated with a Buy at UBS
- 04/06/22 Piper Sandler
- Cano Health downgraded to Underweight from Neutral at Piper Sandler
- 03/31/22 Credit Suisse
- Cano Health assumed with an Outperform at Credit Suisse
- 03/16/22 Citi
- Cano Health price target lowered to $10 from $12 at Citi
- $19.95 /
+3.385 (+20.43%) - 04/21/22 Baird
- Healthcare Services price target raised to $23 from $17 at Baird
- 02/10/22 Jefferies
- Jefferies downgrades Healthcare Services to Underperform on lower earnings power
- 02/10/22 Jefferies
- Healthcare Services downgraded to Underperform from Hold at Jefferies
- 10/21/21 RBC Capital
- Healthcare Services price target lowered to $20 from $29 at RBC Capital
ARCT Arcturus Therapeutics - 04/21/22 Citi
- Arcturus Therapeutics downgraded to Neutral from Buy at Citi
- 04/20/22 H.C. Wainwright
- H.C. Wainwright stays Neutral on Arcturus, awaits full COVID data
- 04/20/22 Piper Sandler
- Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
- 03/22/22 Piper Sandler
- Piper says increased interest to invest in Arcturus validates LUNAR platform
- 04/21/22 Raymond James
- Abbott price target lowered to $135 from $143 at Raymond James
- 04/08/22 Wells Fargo
- Abbott price target lowered to $150 from $155 at Wells Fargo
- 03/01/22 BofA
- Abbott reinstated with a Buy at BofA
- 02/02/22 Piper Sandler
- Boston Scientific thesis unchanged despite margin outlook, says Piper Sandler
- 04/21/22 Susquehanna
- Baker Hughes price target lowered to $41 from $42 at Susquehanna
- 04/21/22 RBC Capital
- Baker Hughes price target lowered to $41 from $43 at RBC Capital
- 04/08/22 Stifel
- Baker Hughes price target raised to $41 from $34 at Stifel
- 03/31/22 Wells Fargo
- Wells Fargo upgrades Baker Hughes to Overweight, raises price target to $43
- 04/21/22 Credit Suisse
- Anthem price target raised to $584 from $518 at Credit Suisse
- 04/07/22 Truist
- Anthem price target raised to $590 from $540 at Truist
- 03/29/22 UBS
- Anthem price target raised to $541 from $477 at UBS
- 03/15/22 SVB Leerink
- Anthem price target raised to $483 from $465 at SVB Leerink
RCI Rogers Communications - 04/14/22 Canaccord
- Rogers Communications price target raised to C$69 from C$65 at Canaccord
- 04/13/22 Scotiabank
- Rogers Communications price target raised to C$87 from C$80 at Scotiabank
- 03/31/22 National Bank
- Rogers Communications price target raised to C$77 from C$74 at National Bank
- 01/28/22 National Bank
- Rogers Communications price target raised to C$74 from C$69 at National Bank
- 02/11/22
- Gundlach sees five interest rate raises in 2022
- $526.34 /
-79.66 (-13.15%) - 02/16/22
- Shopify reports Q4 adjusted EPS $1.36, consensus $1.26
- 02/15/22
- Notable companies reporting before tomorrow's open
- 10/28/21
- Shopify says view on rest of 2021 consistent with assumptions in February
RCI Rogers Communications - 04/20/22
- Rogers Communications raises 2022 revenue view up 6%-8% from up 4%-6%
- 04/20/22
- Rogers Communications reports Q1 adjusted EPS C$0.91 vs. C$0.77 last year
- 01/27/22
- Rogers Communications sees FY22 adjusted EBITDA growth 6%-8%
- 01/27/22
- Rogers Communications reports Q4 EPS C$0.96 vs. C$0.99 a year ago
- 04/14/22
- Rite Aid sees FY23 adjusted EPS ($1.06)-(53c)
- 04/14/22
- Rite Aid reports Q4 EPS ($1.63) vs. (34c) last year
- 12/21/21
- Rite Aid raises FY22 adjusted EPS view to (49c)-(4c) from (90c)-(53c)
- 12/21/21
- Rite Aid reports Q3 adjusted EPS 15c, one estimate (32c)
- 04/20/22
- Procter & Gamble reports Q3 EPS $1.33, consensus $1.29
- 04/19/22
- Notable companies reporting before tomorrow's open
- 01/19/22
- Procter & Gamble backs FY22 core EPS growth 3%-6%, consensus $5.91
- $225.99 /
-122.52 (-35.16%) - 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 04/19/22
- Netflix reports Q1 EPS $3.53, consensus $2.90
- 04/19/22
- Notable companies reporting after market close
- 01/20/22
- Netflix sees Q1 EPS $2.86, consensus $3.45
- $385.44 /
-19.35 (-4.78%) - 03/29/22
- Lululemon sees FY22 EPS $9.15-$9.35, consensus $9.06
- 03/29/22
- Lululemon sees Q1 EPS $1.38-$1.43, consensus $1.29
- 03/29/22
- Lululemon reports Q4 EPS $3.37, consensus $3.28
- 03/29/22
- Notable companies reporting after market close
- $138.30 /
+9.005 (+6.96%) - 04/19/22
- IBM sees FY22 revenue growth at high end of mid-single digit range
- 04/19/22
- IBM reports Q1 adjusted EPS $1.40, consensus $1.38
- 01/24/22
- IBM CEO confident in 'mid-single digit revenue growth' in 2022
- $19.95 /
+3.385 (+20.43%) - 04/20/22
- Healthcare Services reports Q1 EPS 15c, consensus 6c
- 02/09/22
- Healthcare Services reports Q4 EPS 3c, consensus 13c
- 04/19/22
- Halliburton reports Q1 adjusted EPS 35c, consensus 34c
- 04/18/22
- Notable companies reporting before tomorrow's open
- 01/24/22
- Halliburton reports Q4 adjusted EPS 36c, consensus 34c
- $2,565.37 /
-46.84 (-1.79%) - 02/01/22
- Alphabet reports Q4 EPS $30.69, consensus $27.32
- 02/01/22
- Notable companies reporting after market close
- 10/26/21
- Alphabet reports Q3 EPS $27.99, consensus $23.48
- 10/26/21
- Notable companies reporting after market close
- 04/20/22
- Farmers & Merchants reports Q1 EPS 62c, consensus 56c
- 02/14/22
- Farmers & Merchants reports Q4 EPS 66c, consensus 58c
- 10/20/21
- Farmers & Merchants reports Q3 adjusted EPS 63c, consensus 55c
- $200.48 /
-16.78 (-7.72%) - 02/02/22
- Meta sees Q1 revenue $27B-29B, consensus $30.14B
- 02/02/22
- Meta reports Q4 EPS $3.67, consensus $3.84
- 02/02/22
- Notable companies reporting after market close
- 10/25/21
- Facebook reports Q3 EPS $3.22, consensus $3.19
- $319.26 /
+34.93 (+12.29%) - 02/14/22
- Avis Budget reports Q4 adjusted EPS $7.08, consensus $6.15
- 11/01/21
- Avis Budget reports Q3 adjusted EPS $10.74, consensus $6.52
- 03/14/22
- Cano Health raises FY22 adjusted EBITDA view to $230M-$240M from $170M-$175M
- 03/14/22
- Cano Health reports Q4 EPS (12c), consensus (2c)
- 11/09/21
- Cano Health raises FY22 revenue view to $2.6B-$2.7B from $2.5B-$2.6B
- 11/09/21
- Cano Health raises FY21 revenue view to $1.7B from $1.6B, consensus $1.6B
- $120.42 /
+2.865 (+2.44%) - 01/27/22
- Blackstone reports Q4 distributable EPS $1.71, consensus $1.37
- 01/26/22
- Notable companies reporting before tomorrow's open
- 10/21/21
- Blackstone reports Q3 distributable EPS $1.28, consensus 91c
- 04/20/22
- Baker Hughes reports Q1 EPS 15c, consensus 19c
- 04/20/22
- Baker Hughes reports Q1 adjusted EPS 15c, consensus 19c
ARCT Arcturus Therapeutics - 02/28/22
- Arcturus Therapeutics reports Q4 EPS ($1.47), consensus ($1.72)
- 11/08/21
- Arcturus Therapeutics reports Q3 EPS ($2.05), consensus ($1.59)
- 04/20/22
- Anthem now sees FY22 adjusted EPS greater than $28.40, consensus $28.48
- 04/20/22
- Anthem reports Q1 adjusted EPS $8.25, consensus $7.81
- 03/08/22
- Anthem backs FY22 adjusted EPS view greater than $28.25, consensus $28.47
- 01/26/22
- Anthem sees FY22 adjusted EPS greater than $28.25, consensus $28.66
- 11/05/21
- AlloVir reports Q3 EPS (72c), consensus (55c)
- 02/16/22
- Alkermes updates long-term profitability targets for Invega royalty removal
- 02/16/22
- Alkermes sees FY22 adjusted EPS (18c)-0c, consensus 35c
- 02/16/22
- Alkermes reports Q4 adjusted EPS 24c, consensus 8c
- 10/27/21
- Alkermes reports Q3 adjusted EPS 15c, consensus 6c
- 04/20/22
- Abbott backs FY22 adjusted EPS view at least $4.70, consensus $4.83
- 04/20/22
- Abbott reports Q1 adjusted EPS $1.73, consensus $1.46
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< WBD Warner Bros. Discovery - 04/20/22
- Verizon announces HBO Max joins +play
- 04/10/22
- Fly Intel: Top five weekend stock stories
- 04/17/22
- Volta appoints Brandt Hastings as interim CEO
- 03/31/22
- Volta expects 10-K filing to be delayed
- 03/28/22
- Volta falls -18.9%
- 03/28/22
- Volta says Founder Scott Mercer has resigned as CEO
- 04/18/22
- Twitter's former CEO Dorsey criticizes company's board in series of tweets
- 04/17/22
- Fly Intel: Top five weekend stock stories
- 04/15/22
- Twitter adopts 'poison pill' limited duration shareholder rights plan
- $989.15 /
-39.59 (-3.85%) - 04/20/22
- EU passenger car registrations down 20.5% in March
- 04/14/22
- Musk says Twitter board would breach duty by acting against holder interests
- 04/14/22
- Musk asks Prince Alwaleed about Twitter ownership, views on freedom of speech
- 04/14/22
- Musk tweets will try to keep as many shareholders in Twitter as 'allowed by law'
- $541.94 /
-64.06 (-10.57%) - 04/20/22
- Shopify falls -9.6%
- 04/11/22
- Shopify announces planned 10-for-1 split of Class A and Class B shares
- 04/11/22
- Shopify announces proposed updates to governance structure
- 03/28/22
- Shopify purchases carbon removal credits from CarbonBuilt
RCI Rogers Communications - 04/19/22
- Rogers announces production test of 8 gbps symmetrical fibre broadband
- 04/04/22
- Rogers Communications to deploy two more cellular towers along Highway 16
- 04/04/22
- Rogers Communications, OVIN launch 5G transportation challenge
- 03/28/22
- Rogers Communications launches 5G standalone network in Canada
- 04/20/22
- Procter & Gamble seeing 'significant' impact from China lockdowns
- 04/20/22
- P&G expects to repurchase $10B of stock this year, pay over $8B in dividends
- 04/20/22
- Procter & Gamble sees EPS impact of Russia-Ukraine pullback of 4c in Q4
- 04/20/22
- Procter & Gamble backs FY22 core EPS growth view of 3%-6%
- $218.80 /
-129.71 (-37.22%) - 04/19/22
- Netflix says will figure out advertising in next year or two
- 04/19/22
- Netflix says Q2 typically a softer quarter seasonally
- 04/19/22
- Netflix to test ways to charge for account sharing this year
- 04/19/22
- Roku drops 6% to $109.96 after Netflix losses subscribers in Q1
- $392.95 /
-11.84 (-2.92%) - 04/20/22
- Lululemon announces five year growth plan to double revenue to $12.5B by 2026
- 04/12/22
- Lululemon expands Like New resale program to all U.S. stores
- 03/29/22
- Lululemon jumps 7% to $369.33 after FY22 guidance beats estimates
- 03/29/22
- Lululemon authorizes buyback for $1.0B
- $14.70 /
+1.845 (+14.36%) - 03/31/22
- I-Mab announces voluntary lock-ups by key shareholders
- 03/15/22
- I-Mab provides update on the HFCAA and its implementation
- 03/03/22
- I-Mab's TJ-CD4B in gastric cancer granted FDA Orphan Drug Designation
- 03/02/22
- I-Mab granted orphan status for gastric cancer treatment
- $139.40 /
+10.11 (+7.82%) - 04/19/22
- IBM now sees FY22 revenue growth at high end of mid single digit range
- 04/19/22
- IBM up 3% to $133.50 after Q1 results beat estimates
- 04/19/22
- IBM reports Q1 net cash from operating activities of $3.2B; free cash flow $1.2B
- 04/19/22
- IBM CEO says 'we are off to a solid start for the year'
- 04/19/22
- Halliburton records Q1 pre-tax charge of $22M from write down of Ukraine assets
- 04/19/22
- Halliburton sees significant tightness across the entire oil and gas value chain
- 03/18/22
- Halliburton suspends future business in Russia, winds down remaining operations
- 03/08/22
- Halliburton awarded contract by Petrobel
- $2,569.60 /
-28.05 (-1.08%) - 04/14/22
- YouTube, MLB renew pact over MLB Game of the Week Live
- 04/13/22
- Regulator allows WhatsApp to extend payment services to 100M users in India
- 04/13/22
- Google to invest $9.5B in the U.S. in 2022
- 04/12/22
- MongoDB announces pay-as-you-go offering on Google Cloud
- 12/17/21
- Farmers & Merchants raises Q4 cash dividend payment by 11.8% to 19c per share
- $201.70 /
-15.56 (-7.16%) - 04/18/22
- Instagram expanding product tagging in Feed to everyone
- 04/14/22
- WhatsApp debuts Communities, new tools for administrators to monitor abuse
- 04/13/22
- eBay names Eddie Garcia as Chief Product Officer
DWAC Digital World Acquisition - 04/20/22
- Trump-linked SPAC Digital World falls after Kerrisdale short report
- 04/20/22
- Digital World Acquisition SPAC down 8% after being named a short by Kerrisdale
- 03/31/22
- Trump SPAC falls as Truth Social downloads sink 95% from launch
- 03/14/22
- Trump SPAC sinks as Truth Social drops out of App Store's top 125
- $314.74 /
+30.41 (+10.70%) - 11/19/21
- Avis Budget chairman Hees sells 43,389 common shares
- 11/17/21
- Avis Budget chairman sells 100K shares of common stock
- 11/02/21
- Avis Budget halts for volatility after 56% move higher
- 04/20/22
- Cano Health rises 10.5%
- 04/20/22
- Cano Health rises 10.3%
- 04/06/22
- Cano Health falls -9.4%
- 03/15/22
- Cano Health rises 9.4%
- 04/14/22
- Baker Hughes reports U.S. rig count up 4 to 693 rigs
- 04/14/22
- Baker Hughes reports U.S. rig count up 4 to 693 rigs
- 04/08/22
- Baker Hughes reports U.S. rig count up 16 to 689 rigs
- 04/08/22
- Baker Hughes reports U.S. rig count up 16 to 689 rigs
BHLB Berkshire Hills Bancorp - 01/19/22
- Berkshire Hills Bancorp announces $140M share repurchase program
ARCT Arcturus Therapeutics - 04/20/22
- Arcturus: mRNA vaccine candidate ARCT-154 meets primary efficacy endpoint
- 02/23/22
- Avidity Biosciences names Steve Hughes, M.D. as Chief Medical Officer
- 02/14/22
- Arcturus Therapeutics says Hughes steps down as Chief Medical Officer
- 01/25/22
- Arcturus reports new data on ARCT-154 and ARCT-165 booster clinical trial
- 04/20/22
- Anthem: Medical enrollment totaled 46.8M members at March 31
- 03/10/22
- Anthem announces intent to change name to Elevance Health
- 02/03/22
- CMS releases 2023 Medicare Advantage, Part D advance notice
- 01/26/22
- Anthem sees FY22 medical membership 45.6M-46.2M
- 04/20/22
- AlloVir trading resumes
- 04/20/22
- AlloVir trading halted, volatility trading pause
- 04/20/22
- AlloVir receives FDA RMAT designation for posoleucel
- 03/22/22
- AlloVir initiates posoleucel registrational study
- 04/19/22
- Alkermes begins arbitration regarding two license agreements with Janssen
- 02/17/22
- Alkermes presents new data on nemvaleukin alfa monotherapy
- 02/08/22
- Alkermes reports 'positive' results from ENLIGHTEN-Early study
- 01/11/22
- Sarissa intends to nominate directors to Alkermes board
- 04/20/22
- Abbott says seeing more Covid tests, sales
- 04/20/22
- Abbott sees FY22 organic sales growth mid to high single digits
- 04/20/22
- Abbott says continues to strengthen strategic position
- 04/20/22
- Abbott reports Q1 Worldwide Diagnostics sales up 31.7% on a reported basis
- $218.80 /
-129.71 (-37.22%) - 04/20/22 Gordon Haskett
- Netflix quarter 'gut check time' for Bill Ackman, says Gordon Haskett
- 04/20/22 Wedbush
- Netflix price target lowered to $280 from $342 at Wedbush
- 04/20/22 Evercore ISI
- Netflix price target lowered to $300 from $525 at Evercore ISI
- 04/20/22 UBS
- Netflix downgraded to Neutral from Buy at UBS
- $2,569.60 /
-28.05 (-1.08%) - 04/20/22 KeyBanc
- Alphabet, Trade Desk should see the least fundamental risk, says KeyBanc
- 04/19/22 Citi
- Alphabet assumed with a Buy from Neutral at Citi
- 04/19/22 Rosenblatt
- Alphabet initiated with a Buy at Rosenblatt
- 04/14/22 MKM Partners
- Alphabet price target lowered to $3,300 from $3,375 at MKM Partners
- $314.74 /
+30.41 (+10.70%) - 04/20/22 Barclays
- Barclays upgrades Avis to neutral on 'constructive' rental stance
- 04/20/22 Barclays
- Avis Budget upgraded to Equal Weight from Underweight at Barclays
- 04/06/22 BofA
- Avis Budget downgraded to Underperform from Neutral at BofA
- 04/06/22 BofA
- Avis Budget downgraded to Underperform from Neutral at BofA
- 04/20/22 RBC Capital
- Halliburton price target raised to $49 from $45 at RBC Capital
- 04/20/22 Stephens
- Halliburton downgraded to Equal Weight at Stephens following outperformance
- 04/20/22 Stephens
- Halliburton downgraded to Equal Weight from Overweight at Stephens
- 04/20/22 Susquehanna
- Halliburton price target raised to $48 from $45 at Susquehanna
- 04/20/22 Goldman Sachs
- Alkermes initiated with a Buy at Goldman Sachs
- 03/22/22 Citi
- Alkermes price target raised to $26 from $22 at Citi
- 02/17/22 Mizuho
- Alkermes price target raised to $35 from $33 at Mizuho
- 01/27/22 Cantor Fitzgerald
- Alkermes upgraded to Overweight from Neutral at Cantor Fitzgerald
- 04/08/22 Raymond James
- Procter & Gamble initiated with an Outperform at Raymond James
- 04/07/22 Raymond James
- Procter & Gamble initiated with an Outperform at Raymond James
- 04/01/22 Barclays
- Procter & Gamble price target lowered to $167 from $178 at Barclays
- 03/30/22 JPMorgan
- Procter & Gamble downgraded to Neutral from Overweight at JPMorgan
- 04/08/22 Wells Fargo
- Abbott price target lowered to $150 from $155 at Wells Fargo
- 03/01/22 BofA
- Abbott reinstated with a Buy at BofA
- 02/02/22 Piper Sandler
- Boston Scientific thesis unchanged despite margin outlook, says Piper Sandler
- 01/27/22 Raymond James
- Abbott price target lowered to $143 from $150 at Raymond James
- $139.40 /
+10.11 (+7.82%) - 04/20/22 BMO Capital
- IBM price target raised to $152 from $148 at BMO Capital
- 04/20/22 BofA
- IBM price target raised to $165 from $162 at BofA
- 04/20/22 Morgan Stanley
- IBM price target raised to $157 from $150 at Morgan Stanley
- 04/14/22 Morgan Stanley
- IBM upgraded to Overweight from Equal Weight at Morgan Stanley
- $392.95 /
-11.84 (-2.92%) - 04/19/22 Truist
- Lululemon upgraded to Buy from Hold at Truist
- 04/12/22 Stifel
- Lululemon resale expansion 'strategic and shareholder beneficial,' says Stifel
- 04/12/22 Cowen
- Lululemon upside to consensus estimates seen, says Cowen
- 04/07/22 Truist
- Lululemon price target raised to $390 from $386 at Truist
- $14.70 /
+1.845 (+14.36%) - 03/30/22 H.C. Wainwright
- I-Mab price target lowered to $80 from $95 at H.C. Wainwright
- 03/29/22 Piper Sandler
- I-Mab price target lowered to $80 from $90 at Piper Sandler
- 09/03/21 Cantor Fitzgerald
- Cantor Fitzgerald positive on I-Mab following 'solid' first half
- 09/01/21 H.C. Wainwright
- I-Mab price target raised to $95 from $75 at H.C. Wainwright
DWAC Digital World Acquisition - $541.94 /
-64.06 (-10.57%) - 04/19/22 Piper Sandler
- Shopify price target lowered to $800 from $900 at Piper Sandler
- 04/13/22 Benchmark
- Shopify initiated with Hold on 'tough' environment at Benchmark
- 04/13/22 Benchmark
- Shopify initiated with a Hold at Benchmark
- 04/11/22 ATB Capital
- Shopify's 'shareholder friendly changes' positive for shares, says ATB Capital
- $201.70 /
-15.56 (-7.16%) - 04/19/22 Citi
- Meta Platforms assumed with Buy from Neutral at Citi
- 04/19/22 JMP Securities
- Meta Platforms price target lowered to $265 from $350 at JMP Securities
- 04/19/22 Rosenblatt
- Meta Platforms initiated with a Neutral at Rosenblatt
- $989.15 /
-39.59 (-3.85%) - 04/20/22 Gordon Haskett
- Gordon Haskett skeptical Musk tender offer for Twitter comes together
- 04/19/22 Morgan Stanley
- Morgan Stanley highlights four things to watch in Tesla's Q1 report
- 04/19/22 Credit Suisse
- Tesla price target raised to $1,125 from $1,025 at Credit Suisse
- 04/18/22 GLJ Research
- This analyst sees Tesla shares 'tumbling' after Wednesday's earnings
- 03/22/22 Piper Sandler
- Piper 'incrementally positive' on AlloVir after posoleucel data
- 01/31/22 BMO Capital
- AlloVir initiated with an Outperform at BMO Capital
- 01/31/22 BofA
- AlloVir removed from US 1 List at BofA
- 10/19/21 Morgan Stanley
- AlloVir assumed with an Overweight at Morgan Stanley
- 04/20/22 UBS
- Cano Health initiated with a Buy at UBS
- 04/06/22 Piper Sandler
- Cano Health downgraded to Underweight from Neutral at Piper Sandler
- 03/31/22 Credit Suisse
- Cano Health assumed with an Outperform at Credit Suisse
- 03/16/22 Citi
- Cano Health price target lowered to $10 from $12 at Citi
- $19.50 /
+2.935 (+17.72%) - 02/10/22 Jefferies
- Jefferies downgrades Healthcare Services to Underperform on lower earnings power
- 02/10/22 Jefferies
- Healthcare Services downgraded to Underperform from Hold at Jefferies
- 10/21/21 RBC Capital
- Healthcare Services price target lowered to $20 from $29 at RBC Capital
- 10/20/21 William Blair
- Healthcare Services cut to Market Perform after earnings miss at William Blair
ARCT Arcturus Therapeutics - 04/20/22 H.C. Wainwright
- H.C. Wainwright stays Neutral on Arcturus, awaits full COVID data
- 04/20/22 Piper Sandler
- Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
- 03/22/22 Piper Sandler
- Piper says increased interest to invest in Arcturus validates LUNAR platform
- 03/15/22 Citi
- Arcturus Therapeutics price target lowered to $86 from $114 at Citi
- 04/19/22 Goldman Sachs
- Volta downgraded to Sell from Neutral at Goldman Sachs
- 04/19/22 Canaccord
- Volta price target lowered to $2.50 from $3.00 at Canaccord
- 03/28/22 Canaccord
- Canaccord downgrades Volta, sees 'more questions than answers' after CEO exits
- 03/28/22 Canaccord
- Volta downgraded to Hold from Buy at Canaccord
- 04/08/22 Stifel
- Baker Hughes price target raised to $41 from $34 at Stifel
- 03/31/22 Wells Fargo
- Wells Fargo upgrades Baker Hughes to Overweight, raises price target to $43
- 03/31/22 Wells Fargo
- Baker Hughes upgraded to Overweight from Equal Weight at Wells Fargo
- 03/22/22 Goldman Sachs
- Baker Hughes downgraded to Buy from Conviction Buy at Goldman Sachs
- 04/07/22 Truist
- Anthem price target raised to $590 from $540 at Truist
- 03/29/22 UBS
- Anthem price target raised to $541 from $477 at UBS
- 03/15/22 SVB Leerink
- Anthem price target raised to $483 from $465 at SVB Leerink
- 02/07/22 Argus
- Anthem price target raised to $500 from $475 at Argus
BHLB Berkshire Hills Bancorp - 01/09/22 Keefe Bruyette
- Berkshire Hills Bancorp assumed with a Market Perform at Keefe Bruyette
- 08/31/21
- Fly Intel: Top five analyst initiations
- 08/31/21 Seaport Global
- Berkshire Hills Bancorp initiated with Buy, $30 target at Seaport Global
- 08/31/21 Seaport Global
- Berkshire Hills Bancorp initiated with a Buy at Seaport Global
RCI Rogers Communications - 04/14/22 Canaccord
- Rogers Communications price target raised to C$69 from C$65 at Canaccord
- 04/13/22 Scotiabank
- Rogers Communications price target raised to C$87 from C$80 at Scotiabank
- 03/31/22 National Bank
- Rogers Communications price target raised to C$77 from C$74 at National Bank
- 01/28/22 National Bank
- Rogers Communications price target raised to C$74 from C$69 at National Bank
- $2,578.00 /
-34.21 (-1.31%) - 04/13/22 Piper Sandler
- Piper positive on Alphabet and Snap ahead of Q1 earnings from Internet group
- 04/19/22 Citi
- Twitter assumed with a Neutral at Citi
- 04/19/22 Rosenblatt
- Twitter initiated with a Neutral at Rosenblatt
- 04/18/22 Wedbush
- Wedbush sees three paths for Musk given Twitter's poison pill
WBD Warner Bros. Discovery - 04/19/22 Rosenblatt
- Warner Bros. Discovery initiated with a Sell at Rosenblatt
- 04/13/22 BofA
- Warner Bros. Discovery initiated with a Buy at BofA
- 04/13/22 Morgan Stanley
- AT&T price target lowered to $22 at Morgan Stanley post WB deal closing
- 04/11/22 Edward Jones
- Warner Bros. Discovery initiated with a Hold at Edward Jones
- 04/17/22
- Volta reports Q4 revenue $12.14M, consensus $12.13M
- 03/31/22
- Volta sees FY22 revenue $70M-$80M, consensus $88.4M
- 03/31/22
- Volta sees Q1 revenue $8.0M-$8.5M, consensus $16.3M
- 03/31/22
- Volta sees Q4 revenue about $12.0M, consensus $12.3M
- 02/10/22
- Twitter expects FY22 revenue growth in low to mid 20's range
- 02/10/22
- Twitter sees Q1 revenue $1.17B-$1.27B, consensus $1.26B
- 02/10/22
- Twitter reports Q4 adjusted EPS 33c, consensus 35c
- 02/09/22
- Notable companies reporting before tomorrow's open
- $989.15 /
-39.59 (-3.85%) - 01/26/22
- Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26
- 01/26/22
- Notable companies reporting after market close
- 10/20/21
- Tesla reports Q3 non-GAAP EPS $1.86, consensus $1.58
- 10/20/21
- Notable companies reporting after market close
- $541.94 /
-64.06 (-10.57%) - 02/16/22
- Shopify reports Q4 adjusted EPS $1.36, consensus $1.26
- 02/15/22
- Notable companies reporting before tomorrow's open
- 10/28/21
- Shopify says view on rest of 2021 consistent with assumptions in February
RCI Rogers Communications - 04/20/22
- Rogers Communications raises 2022 revenue view up 6%-8% from up 4%-6%
- 04/20/22
- Rogers Communications reports Q1 adjusted EPS C$0.91 vs. C$0.77 last year
- 01/27/22
- Rogers Communications sees FY22 adjusted EBITDA growth 6%-8%
- 01/27/22
- Rogers Communications reports Q4 EPS C$0.96 vs. C$0.99 a year ago
- 04/20/22
- Procter & Gamble reports Q3 EPS $1.33, consensus $1.29
- 04/19/22
- Notable companies reporting before tomorrow's open
- 01/19/22
- Procter & Gamble backs FY22 core EPS growth 3%-6%, consensus $5.91
- $218.80 /
-129.71 (-37.22%) - 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- 04/19/22
- Netflix reports Q1 EPS $3.53, consensus $2.90
- 04/19/22
- Notable companies reporting after market close
- 01/20/22
- Netflix sees Q1 EPS $2.86, consensus $3.45
- $392.95 /
-11.84 (-2.92%) - 03/29/22
- Lululemon sees FY22 EPS $9.15-$9.35, consensus $9.06
- 03/29/22
- Lululemon sees Q1 EPS $1.38-$1.43, consensus $1.29
- 03/29/22
- Lululemon reports Q4 EPS $3.37, consensus $3.28
- 03/29/22
- Notable companies reporting after market close
- $139.40 /
+10.11 (+7.82%) - 04/19/22
- IBM sees FY22 revenue growth at high end of mid-single digit range
- 04/19/22
- IBM reports Q1 adjusted EPS $1.40, consensus $1.38
- 01/24/22
- IBM CEO confident in 'mid-single digit revenue growth' in 2022
- $19.50 /
+2.935 (+17.72%) - 04/20/22
- Healthcare Services reports Q1 EPS 15c, consensus 6c
- 02/09/22
- Healthcare Services reports Q4 EPS 3c, consensus 13c
- 04/19/22
- Halliburton reports Q1 adjusted EPS 35c, consensus 34c
- 04/18/22
- Notable companies reporting before tomorrow's open
- 01/24/22
- Halliburton reports Q4 adjusted EPS 36c, consensus 34c
- $2,569.60 /
-28.05 (-1.08%) - 02/01/22
- Alphabet reports Q4 EPS $30.69, consensus $27.32
- 02/01/22
- Notable companies reporting after market close
- 10/26/21
- Alphabet reports Q3 EPS $27.99, consensus $23.48
- 10/26/21
- Notable companies reporting after market close
- 04/20/22
- Farmers & Merchants reports Q1 EPS 62c, consensus 56c
- 02/14/22
- Farmers & Merchants reports Q4 EPS 66c, consensus 58c
- 10/20/21
- Farmers & Merchants reports Q3 adjusted EPS 63c, consensus 55c
- $201.70 /
-15.56 (-7.16%) - 02/02/22
- Meta sees Q1 revenue $27B-29B, consensus $30.14B
- 02/02/22
- Meta reports Q4 EPS $3.67, consensus $3.84
- 02/02/22
- Notable companies reporting after market close
- 10/25/21
- Facebook reports Q3 EPS $3.22, consensus $3.19
- $314.74 /
+30.41 (+10.70%) - 02/14/22
- Avis Budget reports Q4 adjusted EPS $7.08, consensus $6.15
- 11/01/21
- Avis Budget reports Q3 adjusted EPS $10.74, consensus $6.52
- 03/14/22
- Cano Health raises FY22 adjusted EBITDA view to $230M-$240M from $170M-$175M
- 03/14/22
- Cano Health reports Q4 EPS (12c), consensus (2c)
- 11/09/21
- Cano Health raises FY22 revenue view to $2.6B-$2.7B from $2.5B-$2.6B
- 11/09/21
- Cano Health raises FY21 revenue view to $1.7B from $1.6B, consensus $1.6B
- 04/20/22
- Baker Hughes reports Q1 EPS 15c, consensus 19c
- 04/20/22
- Baker Hughes reports Q1 adjusted EPS 15c, consensus 19c
BHLB Berkshire Hills Bancorp - 04/20/22
- Berkshire Hills Bancorp reports Q1 adjusted EPS 43c, consensus 40c
- 01/20/22
- Berkshire Hills Bancorp reports Q4 adjusted EPS 42c, consensus 42c
- 10/21/21
- Berkshire Hills Bancorp reports Q3 adjusted EPS 53c, consensus $1.12
ARCT Arcturus Therapeutics - 02/28/22
- Arcturus Therapeutics reports Q4 EPS ($1.47), consensus ($1.72)
- 11/08/21
- Arcturus Therapeutics reports Q3 EPS ($2.05), consensus ($1.59)
- 04/20/22
- Anthem now sees FY22 adjusted EPS greater than $28.40, consensus $28.48
- 04/20/22
- Anthem reports Q1 adjusted EPS $8.25, consensus $7.81
- 03/08/22
- Anthem backs FY22 adjusted EPS view greater than $28.25, consensus $28.47
- 01/26/22
- Anthem sees FY22 adjusted EPS greater than $28.25, consensus $28.66
- 11/05/21
- AlloVir reports Q3 EPS (72c), consensus (55c)
- 02/16/22
- Alkermes updates long-term profitability targets for Invega royalty removal
- 02/16/22
- Alkermes sees FY22 adjusted EPS (18c)-0c, consensus 35c
- 02/16/22
- Alkermes reports Q4 adjusted EPS 24c, consensus 8c
- 10/27/21
- Alkermes reports Q3 adjusted EPS 15c, consensus 6c
- 04/20/22
- Abbott backs FY22 adjusted EPS view at least $4.70, consensus $4.83
- 04/20/22
- Abbott reports Q1 adjusted EPS $1.73, consensus $1.46
WBD Warner Bros. Discovery - 04/20/22
- Warner Bros. Discovery reviewing CNN+, plans to cut costs, NY Post reports
- 04/19/22
- Warner Bros. Discovery suspends external marketing spend for CNN+, Axios says
- 04/16/22
- AT&T spinoff worth the wait for shareholders, Barron's says
- 04/14/22
- Warner Bros. Discovery exploring overhaul of DC Entertainment, Variety reports
- 11/07/21
- EV charging stations win jolt of energy in Congress, WSJ says
- 04/20/22
- Musk tweet hints at tender offer for Twitter, WSJ says
- $989.15 /
-39.59 (-3.85%) - 04/20/22
- Musk works to secure financing for $43B Twitter bid, NY Times reports
- 04/19/22
- Blackstone, Brookfield won't provide Musk equity check for Twitter buy, FT says
- 04/19/22
- Florida Governor criticizes Twitter over 'poison pill' provision
- 04/19/22
- Tesla probed by EEOC before California racial discrimination suit, WSJ reports
- $541.94 /
-64.06 (-10.57%) - 04/20/22
- Shopify, Facebook at odds over data, The Information says
- 03/28/22
- NYSE launches probe into unusual Shopify stock surge, NY Magazine says
- 03/10/22
- Pinterest in-app checkout feature currently in beta, Engadget reports
- 03/05/22
- Cloud stocks have become a haven in tech, Barron's says
RCI Rogers Communications - 10/22/21
- Edward Rogers defeats attempt to limit voting power, Bloomberg reports
- 10/21/21
- Rogers chairman seeking to replace five board members, Bloomberg reports
- 10/21/21
- Rogers chairman seeks to replace five existing directors, Bloomberg says
- 03/30/22
- Figs seen by bankers as possible private equity takeout target, Axios says
- 03/19/22
- Chevron, Verizon among dividend stocks to choose for retirement, Barron's says
- 03/09/22
- Nestle to halt all capital investment in Russia, Reuters reports
- 02/12/22
- Caterpillar, Philip Morris could thrive during inflation, Barron's says
- $218.80 /
-129.71 (-37.22%) - 04/11/22
- Netflix to introduce Two Thumbs Up button, Verge reports
- 04/08/22
- NFL has talked about collaborating with Netflix, The Athletic says
- 04/07/22
- Formula 1, WWE could be acquisition targets for streaming companies, CNBC says
- 04/01/22
- Netflix asking employees to be more careful with spending, The Information says
- $392.95 /
-11.84 (-2.92%) - 01/05/22
- Lululemon tells CNBC Nike patents in question 'overly broad and invalid'
- 01/05/22
- Nike lawsuit claims Lululemon infringed patents with Mirror device, CNBC says
- 11/30/21
- Lululemon files patent lawsuit against Peloton, CNBC reports
- 11/26/21
- Peloton sues Lululemon over apparel dispute, CNBC reports
- $14.70 /
+1.845 (+14.36%) - 04/20/22
- I-Mab exploring possible sale amid takeover interest, Bloomberg reports
- 04/20/22
- I-Mab exploring options amid takeover interest, Bloomberg reports
- $139.40 /
+10.11 (+7.82%) - 02/14/22
- IBM executives discussed phasing out 'dinobabies,' NY Times reports
- 01/18/22
- IBM Chief Marketing Officer has left company, Forbes reports
- 01/05/22
- IBM renews efforts to sell Watson Health, looks to fetch over $1B, Axios reports
- 11/27/21
- IBM finally growing again, stock a big bargain, Barron's says
- 12/12/21
- Halliburton, Exxon in discussions for stake in Iraq oil field, Bloomberg says
- $2,569.60 /
-28.05 (-1.08%) - 04/06/22
- Vevo tells Verge it will 'review' security systems following YouTube hack
- 04/06/22
- Google can't punish South Korean app devs for payment workarounds, WSJ says
- 04/06/22
- Google Cloud hiring 200 support staff employees, Business Insider reports
- 03/30/22
- Apple at work on effort to bring more finance services in-house, Bloomberg says
- $201.70 /
-15.56 (-7.16%) - 04/20/22
- WhatsApp strugles to sign up partners for Brazil service, FT reports
- 04/14/22
- Meta's Facebook pulls back from podcasting efforts, Bloomberg says
- 04/13/22
- Meta planning two AR glasses for 2024, The Verge reports
DWAC Digital World Acquisition - 04/20/22
- Digital World Acquisition named as short idea by Kerrisdale Capital
- 04/15/22
- Fox News says didn't authorize account on Truth Social, Axios reports
- 04/12/22
- Fox News is one of biggest brands to join Truth Social, Axios' Dan Primack says
- 04/05/22
- Truth Social executives left after Nunes installed own people, WaPo says
- $314.74 /
+30.41 (+10.70%) - 02/24/22
- Car rental companies expect shortages to continue, WSJ reports
- 03/10/22
- Anthem plans name change to Elevance Health, WSJ reports
- 02/04/22
- California signs secret Medicaid deal with Kaiser Permanente, KHN reports
- 01/11/22
- Insurers to cover rapid Covid-19 tests under White House plan, WSJ reports
- 11/18/21
- Bloomberg survey finds zero of 25 insurers deem Aduhelm 'medically necessary'
- 04/19/22
- CDC 'unlikely' to find link between sickened infants, Abbott plant, WSJ reports
- 03/22/22
- FDA found Abbott Michigan plant unsanitary before formula recall, Bloomberg says
- 03/22/22
- FDA found Abbott Michigan plant unsanitary before formula recall, Bloomberg says
- 01/05/22
- Walmart, Kroger boost prices of at-home Covid-19 test kits, WSJ reports
WBD Warner Bros. Discovery - 04/17/22
- Box Office Battle: 'Fantastic Beasts' wins Easter weekend with $43M debut
- 04/01/22
- What You Missed On Wall Street On Friday
- 04/01/22
- What You Missed On Wall Street This Morning
- 03/28/22
- What You Missed On Wall Street On Monday
- 03/28/22
- What You Missed On Wall Street This Morning
- $989.15 /
-39.59 (-3.85%) - 04/20/22
- Here's what Wall St. experts are saying about Tesla ahead of earnings
- 04/18/22
- What You Missed On Wall Street On Monday
- $541.94 /
-64.06 (-10.57%) - 04/11/22
- What You Missed On Wall Street On Monday
- 04/11/22
- What You Missed On Wall Street This Morning
- 04/11/22
- Fly Intel: Pre-market Movers
- 04/05/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
RCI Rogers Communications - 01/27/22
- Wall Street in Fives - Must Read Lists for Thursday
- 01/27/22
- Wall Street in Fives - Must Read Lists at Midday
- 10/21/21
- Wall Street in Fives - Must Read Lists for Thursday
- 03/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/22/22
- What You Missed On Wall Street On Tuesday
- 03/22/22
- What You Missed On Wall Street This Morning
- $218.80 /
-129.71 (-37.22%) - 04/20/22
- Here's how the Street is reacting to Netflix's 'shocking' subscriber decline
- 04/20/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/20/22
- Fly Intel: Pre-market Movers
- 04/19/22
- Fly Intel: After-Hours Movers
- $139.40 /
+10.11 (+7.82%) - 04/19/22
- Here's what Wall Street is saying about IBM ahead of earnings
- 04/14/22
- What You Missed On Wall Street On Thursday
- 04/14/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $19.50 /
+2.935 (+17.72%) - 02/10/22
- Wall Street in Fives - Must Read Lists for Thursday
- 02/10/22
- Wall Street in Fives - Must Read Lists at Midday
- 02/10/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/19/22
- Fly Intel: Pre-market Movers
- $2,569.60 /
-28.05 (-1.08%) - 04/19/22
- What You Missed On Wall Street On Tuesday
- 04/19/22
- What You Missed On Wall Street This Morning
- 04/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/13/22
- #SocialStocks: Elon Musk passes on Twitter board seat
DWAC Digital World Acquisition - 04/17/22
- Week in SPAC News: Deezer said to near deal to go public
- 04/12/22
- What You Missed On Wall Street On Tuesday
- 04/10/22
- Week in SPAC News: Truth Social executives left after Nunes installed own people
- 04/06/22
- #SocialStocks: Elon Musk gets involved with Twitter, shares and analysts respond
- $314.74 /
+30.41 (+10.70%) - 04/06/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/26/22
- Short Report: Avis Budget, VTEX short interest at multi-week highs
- 02/24/22
- What You Missed On Wall Street On Thursday
- 04/06/22
- What You Missed On Wall Street On Wednesday
- 04/06/22
- What You Missed On Wall Street This Morning
- 03/15/22
- What You Missed On Wall Street This Morning
- 01/20/22
- Wall Street in Fives - Must Read Lists for Thursday
- 01/20/22
- Wall Street in Fives - Must Read Lists at Midday
- 10/25/21
- Fly Insider: Mueller Industries, DraftKings among week's notable insider trades
- 02/03/22
- Wall Street in Fives - Must Read Lists for Thursday
- 02/03/22
- Wall Street in Fives - Must Read Lists at Midday
- 11/01/21
- Fly Insider: Archer Aviation, Anthem among week's notable insider trades
- 12/01/21
- DoorDash upgrade, Krispy Kreme downgrade among today's top Wall Street calls
- 11/08/21
- Fly Intel: After-Hours Movers
- 10/27/21
- Wall Street in Fives - Must Read Lists for Wednesday
- 03/31/22
- Meet BioSig Technologies: Fly exclusive interview with CEO Ken Londoner
- 01/26/22
- Wall Street in Fives - Must Read Lists for Wednesday
WBD Warner Bros. Discovery - 04/14/22
- Notable open interest changes for April 14th
- 04/13/22
- Notable open interest changes for April 13th
- 04/12/22
- Notable open interest changes for April 12th
- 04/11/22
- Two new option listings and one option delisting on April 11th
- 04/08/22
- Largest borrow rate increases among liquid names
- 04/04/22
- Volta options imply 9.1% move in share price post-earnings
- 04/01/22
- Volta options imply 8.7% move in share price post-earnings
- 03/31/22
- Volta options imply 7.8% move in share price post-earnings
- 04/19/22
- Notable open interest changes for April 19th
- 04/18/22
- Notable open interest changes for April 18th
- 04/14/22
- Twitter options volume may top 2M contracts as traders scoff at Musk bid
- $989.15 /
-39.59 (-3.85%) - 04/07/22
- Notable open interest changes for April 7th
- 04/06/22
- Notable open interest changes for April 6th
- 04/05/22
- Notable open interest changes for April 5th
- 04/04/22
- Notable open interest changes for April 4th
- $541.94 /
-64.06 (-10.57%) - 12/16/21
- Unusually active option classes on open December 16th
- 11/30/21
- Unusually active option classes on open November 30th
- 10/28/21
- Unusually active option classes on open October 28th
- 04/20/22
- Unusually active option classes on open April 20th
- 03/01/22
- Procter & Gamble put volume heavy and directionally bearish
- 02/25/22
- Unusually active option classes on open February 25th
- 01/21/22
- Procter & Gamble call volume above normal and directionally bullish
- $218.80 /
-129.71 (-37.22%) - 04/20/22
- Notable open interest changes for April 20th
- 04/19/22
- Netflix options imply 9.2% move in share price post-earnings
- 02/18/22
- Early notable gainers among liquid option names on February 18th
- 01/31/22
- Early notable gainers among liquid option names on January 31st
- $392.95 /
-11.84 (-2.92%) - 03/29/22
- Lululemon options imply 7.1% move in share price post-earnings
- 02/03/22
- Lululemon put volume heavy and directionally bearish
- 01/10/22
- Unusually active option classes on open January 10th
- 12/09/21
- Lululemon options imply 7.1% move in share price post-earnings
- $139.40 /
+10.11 (+7.82%) - 04/20/22
- Early notable gainers among liquid option names on April 20th
- 04/19/22
- IBM options imply 4.1% move in share price post-earnings
- 04/14/22
- IBM call volume above normal and directionally bullish
- 04/14/22
- Early notable gainers among liquid option names on April 14th
- 04/19/22
- Unusually active option classes on open April 19th
- 04/18/22
- Halliburton call volume above normal and directionally bullish
- 04/18/22
- Early notable gainers among liquid option names on April 18th
- 03/10/22
- Halliburton call volume above normal and directionally bullish
- $2,569.60 /
-28.05 (-1.08%) - 02/03/22
- Unusually active option classes on open February 3rd
- 02/02/22
- Early notable gainers among liquid option names on February 2nd
- 02/01/22
- Alphabet Class A options imply 4.5% move in share price post-earnings
- 01/04/22
- Alphabet Class A call volume above normal and directionally bullish
- $2,578.00 /
-34.21 (-1.31%) - 02/01/22
- Alphabet options imply 4.5% move in share price post-earnings
- $201.70 /
-15.56 (-7.16%) - 03/25/22
- Early notable gainers among liquid option names on March 25th
- 03/24/22
- Facebook call volume above normal and directionally bullish
- 03/17/22
- Notable open interest changes for March 17th
- 03/16/22
- Notable open interest changes for March 16th
DWAC Digital World Acquisition - 03/24/22
- Largest borrow rate increases among liquid names
- 03/11/22
- Digital World Acquisition Corp put volume heavy and directionally bearish
- 03/02/22
- Digital World Acquisition Corp call volume above normal and directionally bullish
- 02/24/22
- Largest borrow rate increases among liquid names
- $314.74 /
+30.41 (+10.70%) - 02/14/22
- Avis Budget options imply 19.8% move in share price post-earnings
- 11/02/21
- Baby you can drive my CAR calls up 3400% as shares skyrocket post earnings
- 11/01/21
- Avis Budget options imply 12.2% move in share price post-earnings
- 03/10/22
- Unusually active option classes on open March 10th
- 03/21/22
- Baker Hughes put volume heavy and directionally bearish
- 03/07/22
- Early notable gainers among liquid option names on March 7th
- 02/11/22
- Early notable gainers among liquid option names on February 11th
- 01/20/22
- Early notable gainers among liquid option names on January 20th
- 02/18/22
- Abbott put volume heavy and directionally bearish
- 01/31/22
- Unusually active option classes on open January 31st
- 01/26/22
- Unusually active option classes on open January 26th
|